Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma ; volume:102 ; number:4 ; year:2021 ; pages:622-629 ; extent:8
Digestion ; 102, Heft 4 (2021), 622-629 (gesamt 8)
- Creator
-
Suzuki, Yugo
Kikuchi, Daisuke
Hoteya, Shu
Okamura, Takayuki
Ochiai, Yorinari
Hayasaka, Junnosuke
Dan, Nobuhiro
Mitsunaga, Yutaka
Tanaka, Masami
Odagiri, Hiroyuki
Nomura, Kosuke
Yamashita, Satoshi
Matsui, Akira
Iizuka, Toshiro
- DOI
-
10.1159/000510368
- URN
-
urn:nbn:de:101:1-2021072200321138892224
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Suzuki, Yugo
- Kikuchi, Daisuke
- Hoteya, Shu
- Okamura, Takayuki
- Ochiai, Yorinari
- Hayasaka, Junnosuke
- Dan, Nobuhiro
- Mitsunaga, Yutaka
- Tanaka, Masami
- Odagiri, Hiroyuki
- Nomura, Kosuke
- Yamashita, Satoshi
- Matsui, Akira
- Iizuka, Toshiro
Other Objects (12)
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Esophageal squamous papilloma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Esophageal squamous papilloma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Esophageal squamous papilloma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma